- Home
- Publications
- Publication Search
- Publication Details
Title
Functional roles of lncRNA-TUG1 in hepatocellular carcinoma
Authors
Keywords
-
Journal
LIFE SCIENCES
Volume 308, Issue -, Pages 120974
Publisher
Elsevier BV
Online
2022-09-18
DOI
10.1016/j.lfs.2022.120974
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis
- (2022) Le Lu et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Cancer as a Metabolic Disorder
- (2022) Jones Gyamfi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
- (2022) Yudong Liu et al. Molecular Cancer
- Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway
- (2022) Qing Tang et al. MOLECULAR CARCINOGENESIS
- A novel regulatory mechanism network mediated by lncRNA TUG1 that induces the impairment of spiral artery remodeling in preeclampsia
- (2022) Yetao Xu et al. MOLECULAR THERAPY
- Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma
- (2022) Yanyi Ren et al. Journal of Immunology Research
- Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy
- (2022) Cuifeng Xia et al. Bioengineered
- LncRNA TUG1 functions as a ceRNA for miR‐1‐3p to promote cell proliferation in hepatic carcinogenesis
- (2022) Keke Tang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance
- (2022) Hyun Yang et al. JOURNAL OF HEPATOLOGY
- Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives
- (2022) Jia Song et al. Molecular Cancer
- Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma
- (2022) Lin Wang et al. Genes
- P53 and taurine upregulated gene 1 promotes the repair of the DeoxyriboNucleic Acid damage induced by bupivacaine in murine primary sensory neurons
- (2022) Luying Lai et al. Bioengineered
- Emerging role of LINC00461 in cancer
- (2022) Qiudan Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
- (2022) Majid Ghasemian et al. Cancer Cell International
- A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
- (2022) Genhao Zhang et al. Scientific Reports
- The advanced development of molecular targeted therapy for hepatocellular carcinoma
- (2022) Tao Yan et al. Cancer Biology & Medicine
- Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis
- (2022) Sajad Najafi et al. EXPERIMENTAL CELL RESEARCH
- Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
- (2021) Ruijuan Du et al. Molecular Cancer
- Hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes
- (2021) Tingting Shi et al. Journal of Hepatocellular Carcinoma
- Role of long noncoding RNA taurine‐upregulated gene 1 in cancers
- (2021) Miao Da et al. MOLECULAR MEDICINE
- lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2
- (2021) Yiqiang Cao et al. Molecular Medicine Reports
- lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma
- (2021) Miao-Xian Yuan et al. Molecular Medicine Reports
- Emodin inhibits the progression of acute pancreatitis via regulation of lncRNA TUG1 and exosomal lncRNA TUG1
- (2021) Xiumei Wen et al. Molecular Medicine Reports
- Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges
- (2021) Manoja K. Brahma et al. ONCOGENE
- Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management
- (2021) Hrishikesh Samant et al. Journal of Gastrointestinal Oncology
- HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease
- (2021) Georg Semmler et al. JOURNAL OF HEPATOLOGY
- Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance
- (2021) Negin Raei et al. LIFE SCIENCES
- Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
- (2021) Mina S Makary et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long non-coding RNA TUG1 promotes cell progression in hepatocellular carcinoma via regulating miR-216b-5p/DLX2 axis
- (2020) Qun Dai et al. Cancer Cell International
- TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma
- (2020) Yang-Hsiang Lin et al. Cells
- Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1
- (2020) Jianyin Long et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
- (2020) Chongxian Pan et al. Journal of Hematology & Oncology
- The role of long noncoding RNAs in hepatocellular carcinoma
- (2020) Zhao Huang et al. Molecular Cancer
- TUG1 Promoted Tumor Progression by Sponging miR-335-5p and Regulating CXCR4-Mediated Infiltration of Pro-Tumor Immunocytes in CTNNB1-Mutated Hepatoblastoma
- (2020) Fujing Xie et al. OncoTargets and Therapy
- Inflammatory Mechanisms of HCC Development
- (2020) Maria Grazia Refolo et al. Cancers
- Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma
- (2020) Mai Mohyeldeen et al. CLINICAL BIOCHEMISTRY
- Tissue-based long non-coding RNAs “PVT1, TUG1 and MEG3” signature predicts Cisplatin resistance in ovarian Cancer
- (2020) Nashwa El-Khazragy et al. GENOMICS
- Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application
- (2020) Yu-Meng Sun et al. Journal of Hematology & Oncology
- lncRNA TUG1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma via Regulating miR-29c-3p/COL1A1 Axis
- (2020) Wei Zhao et al. Cancer Management and Research
- Synthesis and biological assessment of ciprofloxacin-derived 1,3,4-thiadiazoles as anticancer agents
- (2020) Hamideh Ahadi et al. BIOORGANIC CHEMISTRY
- JAK2-mediated intracellular signaling
- (2020) Mentor Sopjani et al. CURRENT MOLECULAR MEDICINE
- Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
- (2020) Sahin Lacin et al. Journal of Hepatocellular Carcinoma
- Malignancy and IFITM3: Friend or Foe?
- (2020) Ushani S. Rajapaksa et al. Frontiers in Oncology
- Overexpressed long noncoding RNA TUG1 affects the cell cycle, proliferation, and apoptosis of pancreatic cancer partly through suppressing RND3 and MT2A
- (2019) Bingqing Hui et al. OncoTargets and Therapy
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer
- (2019) Gan Yu et al. Molecular Therapy-Nucleic Acids
- Long non‐coding RNAs (CASC2 and TUG1) in hepatocellular carcinoma: Clinical significance
- (2019) Noha S. Refai et al. JOURNAL OF GENE MEDICINE
- Long Non-coding RNA TUG1 Sponges Mir-145a-5p to Regulate Microglial Polarization After Oxygen-Glucose Deprivation
- (2019) Haoyue Wang et al. Frontiers in Molecular Neuroscience
- Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells
- (2019) Kehe Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pathophysiological Functions of the lncRNA TUG1
- (2019) Chong Guo et al. CURRENT PHARMACEUTICAL DESIGN
- Biomarker definitions and their applications
- (2018) Robert M Califf EXPERIMENTAL BIOLOGY AND MEDICINE
- LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma
- (2018) Jun Lv et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma
- (2018) Jianwen Long et al. MEDICAL SCIENCE MONITOR
- The Big Entity of New RNA World: Long Non-Coding RNAs in Microvascular Complications of Diabetes
- (2018) Satish K. Raut et al. Frontiers in Endocrinology
- Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer
- (2018) Tielei Tang et al. BIOMEDICINE & PHARMACOTHERAPY
- lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1
- (2018) Chuan He et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384
- (2018) Wei Qian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Unlocking the potential of HK2 in cancer metabolism and therapeutics
- (2018) Sara N. Garcia et al. CURRENT MEDICINAL CHEMISTRY
- Wnt–β-catenin signalling in liver development, health and disease
- (2018) Maria J. Perugorria et al. Nature Reviews Gastroenterology & Hepatology
- Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma
- (2017) Yang-Hsiang Lin et al. HEPATOLOGY
- Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2
- (2017) Yuchun Niu et al. Molecular Cancer
- Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications
- (2017) Zhao-Shan Niu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The long noncoding RNA TUG1 acts as a competing endogenous RNA to regulate the Hedgehog pathway by targeting miR-132 in hepatocellular carcinoma
- (2017) Jingjing Li et al. Oncotarget
- Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression
- (2017) Jiali Zhang et al. Journal of Cancer
- Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration
- (2017) Yingying Hu et al. Cancer Medicine
- Thyroid hormone suppresses hepatocarcinogenesis via DAPK2 and SQSTM1-dependent selective autophagy
- (2016) Hsiang-Cheng Chi et al. Autophagy
- Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
- (2016) Chloé Sauzay et al. CLINICA CHIMICA ACTA
- Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics
- (2016) Ting Shi et al. DISEASE MARKERS
- Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma
- (2016) Jinxia Liu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Genotype-phenotype correlation ofCTNNB1mutations reveals different ß-catenin activity associated with liver tumor progression
- (2016) Sandra Rebouissou et al. HEPATOLOGY
- Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy
- (2016) Jianyin Long et al. JOURNAL OF CLINICAL INVESTIGATION
- CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
- (2016) Guoqing Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition
- (2016) Junfeng Sun et al. Journal of Translational Medicine
- Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis
- (2016) Chunyang Jiang et al. Molecular Cancer
- Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma
- (2016) R Dong et al. Cell Death & Disease
- Evidence of cancer-promoting roles for AMPK and related kinases
- (2015) Tiziana Monteverde et al. FEBS Journal
- Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells
- (2015) Jiemei Tan et al. FEBS LETTERS
- Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2
- (2015) Ming-De Huang et al. Molecular Cancer
- Evaluation of 11C-Acetate and 18 F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma
- (2015) Paul R. Territo et al. BMC MEDICAL IMAGING
- Noncoding RNAs and Atherosclerosis
- (2014) Binod Aryal et al. Current Atherosclerosis Reports
- Biomarker validation and testing
- (2014) Daniel F. Hayes Molecular Oncology
- P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression
- (2014) E-b Zhang et al. Cell Death & Disease
- Thyroid hormone actions in liver cancer
- (2012) Sheng-Ming Wu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- TGF-β signaling and epithelial–mesenchymal transition in cancer progression
- (2012) Yoko Katsuno et al. CURRENT OPINION IN ONCOLOGY
- Cancer biomarkers
- (2012) N. Lynn Henry et al. Molecular Oncology
- Diagnostic performance of the PCA3 urine test
- (2011) George Leighton Lee et al. Nature Reviews Urology
- PCA3: From basic molecular science to the clinical lab
- (2010) John R. Day et al. CANCER LETTERS
- What are biomarkers?
- (2010) Kyle Strimbu et al. Current Opinion in HIV and AIDS
- Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
- (2009) Ahmad M. Khalil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States
- (2008) Manal M. Hassan et al. HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started